Theravance Biopharma, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Theravance Biopharma announces its 2026 Annual General Meeting to be held on June 12, 2026, in Dublin, Ireland.
NASDAQ
Theravance Biopharma will hold its 2025 Annual General Meeting on May 19, 2025, in Dublin, Ireland, to vote on director elections, auditor ratification, and executive compensation.
NASDAQ
Theravance Biopharma will hold its 2024 Annual General Meeting on May 8, 2024, in Dublin, Ireland, to vote on director elections, auditor ratification, and executive compensation.